Navigation Links
Leading ALS Researcher Joins the Kansas City University of Medicine and Biosciences
Date:8/14/2014

KANSAS CITY, Mo., Aug.14, 2014 /PRNewswire-USNewswire/ -- The Kansas City University of Medicine and Biosciences (KCUMB) announces the appointment of Jingsong Zhou, Ph.D., as a research investigator and professor of physiology in the College of Osteopathic Medicine. Dr. Zhou is an internationally renowned researcher and an important addition to KCUMB's growing research efforts. KCUMB recently made a strategic shift to focus on advancing the scientific exploration of biomedical and translational research.

Dr. Zhou is an international leader in neuromuscular disease research, including amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's Disease. Dr. Zhou is recognized for her significant contributions to advancing the scientific understanding in those, and other neurologic conditions such as Alzheimer's Disease. She has been on the cutting edge of biotechnology of Calcium imaging in living cells and is credited for the development of molecular biosensors of the mitochondria (the power plant for all cells) which has broad applications in a number of diseases.

Dr. Zhou brings the unique perspective of a biophysicist to understanding neuromuscular diseases, and is a well-funded investigator by the National Institutes of Health. She was most recently an associate professor in the Department of Molecular Physiology and Biophysics at Rush University School of Medicine in Chicago. Prior to her tenure at Rush University she was a research associate for the Department of Pharmacology at Vanderbilt University in Nashville, Tenn., and served as a teaching and research assistant for the Department of Physiology at Hunan Medical University in China.

"KCUMB is honored to welcome an internationally recognized research expert, Dr. Zhou, to our team," said Jeffrey Joyce, Ph.D., vice president for research. "Dr. Zhou brings years of expertise in molecular biophysics and physiology research, a collaborative entrepreneurial outlook to research and we look forward to her leadership and impact here at KCUMB and within the region's research community."

As research investigator, Dr. Zhou's responsibilities will include leading key biomedical and translational research initiatives, particularly in the neuroscience arena, collaborating with researchers at other local organizations, including the Kansas City Area Life Sciences Institute and its key stakeholders, and providing student research opportunities.

"We are delighted Dr. Zhou is joining KCUMB," said Dr. Richard Barohn, vice chancellor for research at the University of Kansas Medical Center. "In doing so, she will become a member of Frontiers: The Heartland for Clinical and Translational Research and will work with a number of scientists exploring the pathogenesis of severe neurodegenerative disorders such as ALS and Alzheimer's disease.  With Dr. Zhou's hire, we have developed a critical mass of cutting edge researchers who are making important discoveries in these diseases."

With this hire KCUMB is committing significant resources to expand its laboratory facilities on campus, establish a scientific core in the neurosciences and invest in additional scientific research equipment to enhance these new research efforts.

"Dr. Zhou and her staff will be key components of enhanced neuroscience research not only on the KCUMB campus, but her unique research focus will be a resource to the greater Kansas City scientific community," said Marc B. Hahn, D.O., president and chief executive officer for KCUMB. "She will truly add to the scholarly foundation of our University and be a mentor for our students."

Dr. Zhou is the recipient of the Outstanding Research Award from the Sigma Xi Scientific Research Society, the Medical Staff Award from Rush University, and the American Heart Association Fellowship Award. Dr. Zhou has been a member of the Biophysical Society since 1993, and a member of the American Physiology Society since 2013.

She earned her doctorate in physiology and biophysics from Rush University in July 1997.

About KCUMB
The Kansas City University of Medicine and Biosciences, founded in 1916, is a fully accredited, private university, with a College of Biosciences and a College of Osteopathic Medicine. The College of Osteopathic Medicine is the oldest medical school in Kansas City, Mo., and the largest in the state. It is the second-largest provider of physicians within the states of Missouri and Kansas, with 73 percent practicing in a primary care specialty throughout the Midwest region.

Contact: Brian Van Note
Account Executive
(913) 660-9656
(816) 810-7785 (cell)
bvannote@morningstarcomm.com

Lisa Cambridge
Director of Public Relations
(816) 654-7038
(913) 602-8652 (cell)
lcambridge@kcumb.edu


'/>"/>
SOURCE Kansas City University of Medicine and Biosciences (KCUMB)
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. Clinovo White Papers Published in Summer 2014 Editions of Leading Medical Device & Pharmaceutical Publications
2. Proove Biosciences Exhibits Industry Leading Data and Research at International Spine Intervention Society’s 22nd Annual Scientific Meeting
3. Leading Cancer Immunotherapy Biotech Startup Announces New Investments, Leadership Appointments
4. Menon Biosensors Demonstrates Industry Leading Sensitivity Levels for Detection of Tuberculosis and Clostridium difficile
5. WaferGen Bio-systems Acquires a Leading Next-Generation Sequencing (NGS) Library Preparation Business and Announces Changes to its Board of Directors
6. New 2 Hour Educational Learning Labs at MD&M West Will Feature Baxter Bioscience, BMW, Dell, GE Healthcare, Mattel, Northrup Grumman, Starbucks and Other Leading Groups in Design, Manufacturing, Engineering and Automation
7. Arsenal Capital Partners Acquires Leading Model-Based Drug Development Company Certara
8. Gregory Frank Named President of Two Leading Immunology Biotech Companies; Pure Protein and Pure MHC
9. Leading Cancer Research Centers Team Up To Launch Biotech Startup Focused On Cancer Immunotherapy
10. The Future is Bright for Formedix, Leading Clinical Trial Software Provider
11. NSF International Acquires Brazil’s Bioensaios Analysis and Environmental Consultancy Ltd., a Leading Analytical Laboratory
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... -- The Prostate Cancer Foundation (PCF) is pleased to announce 24 new ... prostate cancer. Members of the Class of 2016 were selected from a pool ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... , ... June 23, 2016 , ... STACS DNA Inc., ... Leader at the Arkansas State Crime Laboratory, has joined STACS DNA as a Field ... DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding ...
(Date:6/23/2016)... LONDON , June 23, 2016 ... & Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... Review , the peer-reviewed journal from touchONCOLOGY, ... the escalating cost of cancer care is placing ... a result of expensive biologic therapies. With the ...
Breaking Biology Technology:
(Date:4/15/2016)... 2016 Research and Markets has ... Market 2016-2020,"  report to their offering.  , ... ,The global gait biometrics market is expected to ... period 2016-2020. Gait analysis generates multiple ... used to compute factors that are not or ...
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting ... are setting a new clinical standard in telehealth thanks ... By leveraging the higi platform, IMPOWER patients can routinely ... pulse and body mass index, and, when they opt ... and convenient visit to a local retail location at ...
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
Breaking Biology News(10 mins):